These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 4993272)
1. Specific and nonspecific stimulation of resistance in mice aganist infection with Mycobacterium tuberculosis H37Rv. Ribi E; Brehmer W; Milner KC; Wicht WC Pneumonologie; 1970; 142(2):264-73. PubMed ID: 4993272 [No Abstract] [Full Text] [Related]
2. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894 [TBL] [Abstract][Full Text] [Related]
3. Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis. Aldwell FE; Brandt L; Fitzpatrick C; Orme IM Infect Immun; 2005 Mar; 73(3):1903-5. PubMed ID: 15731098 [TBL] [Abstract][Full Text] [Related]
4. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen. Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130 [TBL] [Abstract][Full Text] [Related]
5. BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice. Pedroza-Roldán C; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; Aceves-Sánchez MJ; Hernández Pando R; Flores-Valdez MA Tuberculosis (Edinb); 2018 Dec; 113():19-25. PubMed ID: 30514503 [TBL] [Abstract][Full Text] [Related]
6. Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection. Nambiar JK; Ryan AA; Kong CU; Britton WJ; Triccas JA Eur J Immunol; 2010 Jan; 40(1):153-61. PubMed ID: 19830735 [TBL] [Abstract][Full Text] [Related]
7. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819 [TBL] [Abstract][Full Text] [Related]
8. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice. Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of vaccine-induced resistance in a guinea pig model of pulmonary tuberculosis. McMurray DN; Dai G; Phalen S Tuber Lung Dis; 1999; 79(4):261-6. PubMed ID: 10692995 [No Abstract] [Full Text] [Related]
10. Heterologous Boost Following Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X Front Immunol; 2018; 9():2439. PubMed ID: 30425711 [TBL] [Abstract][Full Text] [Related]
11. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. Castillo-Rodal AI; Castañón-Arreola M; Hernández-Pando R; Calva JJ; Sada-Díaz E; López-Vidal Y Infect Immun; 2006 Mar; 74(3):1718-24. PubMed ID: 16495544 [TBL] [Abstract][Full Text] [Related]
12. Development of live recombinant vaccine candidates against tuberculosis. Hess J; Kaufmann SH Scand J Infect Dis; 2001; 33(10):723-4. PubMed ID: 11728033 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis. Yamamoto K; Granger DL; Brehmer W; Azuma I; Ribi E Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):127-41. PubMed ID: 6797153 [TBL] [Abstract][Full Text] [Related]
14. Controlling tuberculosis: the pathologist's point of view. Dannenberg AM Res Microbiol; 1990 Feb; 141(2):192-6; discussion 262-3. PubMed ID: 2111920 [No Abstract] [Full Text] [Related]
15. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin. Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102 [TBL] [Abstract][Full Text] [Related]
16. Rational vaccine development--a new trend in tuberculosis control. Kaplan G N Engl J Med; 2005 Oct; 353(15):1624-5. PubMed ID: 16221789 [No Abstract] [Full Text] [Related]
17. [Inoculation of bacille calmette guerin combined with intraperitoneal adenosine injection enhances antibacterial effect of macrophage against Mycobacterium tuberculosis in mice]. Pan JH; Lou WL; Zhou HQ; Shen HY; Chen LJ Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):932-5. PubMed ID: 15733366 [TBL] [Abstract][Full Text] [Related]